-   Training & Support

[Expand/Collapse all sections]Expand all

This document outlines details of PBS subsidised riociguat for patients
with chronic thromboembolic pulmonary hypertension (CTEPH).

CTEPH and listing dates

CTEPH is a condition resulting in blood flow obstruction through the
lungs.

Listing date:

-   riociguat - 1 January 2017

See Written Authority Required Drugs for more information.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Programs team and choose the option relevant to the condition
treated.

The Resources page contains links to application forms, contact details,
item and restriction codes, the PBS schedule and Services Australia
website.

Related links

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA
System)

Process telephone authority approval application

Processing and National Demand Allocation (PaNDA)

Processing Complex Authority Required Listings

Written Authority Required Drugs

                                   

-   Services Australia ABN 90 794 605 008 
